144 - November 24, 2025 | SEC Filings

Brief

Rocket Lab officer Arjun Kampani filed Form 144 on 2025-11-24 notifying intent to sell 28,615 common shares (aggregate value ~$1.16M) on or around 11/24/2025. Shares stem from recent restricted stock vesting on 11/22/2025, with sale proceeds covering tax obligations. This routine insider transaction follows prior sales totaling ~40,601 shares in September 2025.

Detailed Brief

Form 144 discloses proposed sale of 28,615 Rocket Lab common shares by officer Arjun Kampani, an executive at the company (CIK 0001671507). The shares include 21,096 (market value $857,588) and 7,519 ($305,660), against 534M shares outstanding, via Morgan Stanley. These were acquired via vesting of 38,685 and 13,787 restricted stock units on 11/22/2025 as compensation. The filing notes the sale covers tax obligations from the vesting event, a standard practice for insiders. Kampani previously sold ~40,601 shares in September 2025 for ~$1.97M. No material adverse information is indicated, and the signature affirms compliance with Rule 144 and no undisclosed issues.

Key Telemetry

• Arjun Kampani (Officer) to sell 28,615 common shares (~$1.16M value) on 11/24/2025.

• Shares from RSU vesting on 11/22/2025: total 52,472 units acquired as compensation.

• Sale to cover taxes on vested equity; routine transaction.

• Prior 3-month sales: 40,601 shares for ~$1.97M in Sept 2025.

• No indication of 10b5-1 plan or other special arrangements.

Impact Vector

Routine insider sale to cover taxes has minimal near-term impact on RKLB stock, representing negligible dilution (~0.005% of shares outstanding). Signals standard executive compensation practices amid ongoing equity grants in growth-stage space firm. Investors should monitor aggregate insider selling trends and upcoming earnings for liquidity or cash burn insights, but no strategic concerns here.